Ensysce Biosciences (ENSC) Shares Outstanding (2017 - 2025)
Ensysce Biosciences' Shares Outstanding came in at 2.56 million for Q4 2025, up 266.6% from 697,686 a year earlier but down 11.4% from the prior quarter.
Powered by 
Analysis
Ensysce Biosciences (ENSC) Shares Outstanding (2017 - 2025) Analysis & Trends
Going back to Q4 2017, Ensysce Biosciences' Shares Outstanding data covers 33 quarters.
- Shares Outstanding carries a five-year compound annual growth rate of 328.6% (FY2020 to FY2025).
- Going back by year, Shares Outstanding was 697,686 in FY2024 (+362.2%), 150,945 in FY2023, 11,996 in FY2022 (+114.2%) and 5,601 in FY2021 (+216.6%).
- The five-year range for quarterly Shares Outstanding is 1,729 (Q1 2021) to 2.89 million (Q3 2025).
- Year-over-year, Shares Outstanding has increased for eight consecutive quarters, with growth averaging 307.3% over the last eight quarters.
- The fastest year-over-year change in Shares Outstanding over five years came in Q1 2023 (growth of 827.2%), and the weakest in Q1 2021 (a decline of 2.4%).
- Business Quant data shows ENSC's Shares Outstanding at 2.89 million (Q3 2025), 2.2 million (Q2 2025) and 1.4 million (Q1 2025) in the three quarters before Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 2.41 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 1.77 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.47 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 1.94 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 1.55 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 540.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.24 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 5.70 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 253.70 Mn |
| 10 | Ensysce Biosciences | 1.07 Mn | -10.50 Mn | - | 2.56 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 2.56 Mn |
| Sep 30, 2025 | 2.89 Mn |
| Jun 30, 2025 | 2.20 Mn |
| Mar 31, 2025 | 1.40 Mn |
| Dec 31, 2024 | 697,686.00 |
| Sep 30, 2024 | 659,392.00 |
| Jun 30, 2024 | 587,850.00 |
| Mar 31, 2024 | 379,650.00 |
| Dec 31, 2023 | 150,945.00 |
| Sep 30, 2023 | 205,735.00 |
| Jun 30, 2023 | 151,615.00 |
| Mar 31, 2023 | 70,284.00 |
| Dec 31, 2022 | 11,996.00 |
| Sep 30, 2022 | 10,715.00 |
| Jun 30, 2022 | 9,441.00 |
| Mar 31, 2022 | 7,580.00 |
| Dec 31, 2021 | 5,601.00 |
| Sep 30, 2021 | 6,738.00 |
| Jun 30, 2021 | 4,459.00 |
| Mar 31, 2021 | 1,729.00 |
API Access
Ensysce Biosciences Shares Outstanding API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding&ticker=ENSC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding", "ticker": "ENSC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding&ticker=ENSC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();